1. Home
  2. AHT vs ITRM Comparison

AHT vs ITRM Comparison

Compare AHT & ITRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

AHT

Ashford Hospitality Trust Inc

HOLD

Current Price

$3.88

Market Cap

26.2M

Sector

Real Estate

ML Signal

HOLD

Logo Iterum Therapeutics plc

ITRM

Iterum Therapeutics plc

HOLD

Current Price

$0.42

Market Cap

24.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AHT
ITRM
Founded
2003
2015
Country
United States
Ireland
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
26.2M
24.3M
IPO Year
2003
2018

Fundamental Metrics

Financial Performance
Metric
AHT
ITRM
Price
$3.88
$0.42
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$9.00
AVG Volume (30 Days)
344.8K
1.2M
Earning Date
11-04-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,119,102,000.00
$390,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$325.95
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.90
$0.36
52 Week High
$10.35
$2.18

Technical Indicators

Market Signals
Indicator
AHT
ITRM
Relative Strength Index (RSI) 49.87 39.30
Support Level $3.05 $0.44
Resistance Level $4.80 $0.49
Average True Range (ATR) 0.34 0.04
MACD 0.17 0.01
Stochastic Oscillator 51.89 15.81

Price Performance

Historical Comparison
AHT
ITRM

About AHT Ashford Hospitality Trust Inc

Ashford Hospitality Trust Inc. is a real estate investment trust that invests in full-service upscale and upper-upscale hotel properties in the U.S. The company owns and operates its assets through its operating partnership, Ashford Hospitality Limited Partnership. All of its hotels are located across the U.S. and operate under the Marriott, Hilton, Hyatt, Crowne Plaza, and Sheraton brands. Ashford's sole segment is Direct Hotel Investments, through which it owns hotels by acquisition or development. Ashford also provides real estate investment services, such as mezzanine financing, first mortgage financing, and sales-leaseback transactions. Its revenue streams include Room revenue, Food and beverage revenue, and Other revenue. Room revenue accounts for the majority of total revenue.

About ITRM Iterum Therapeutics plc

Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.

Share on Social Networks: